SCHEMBL6308207

SCHEMBL6308207

CCN(CCO)c1ccc(N=O)c(C)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.52
RAB9A P51151 6/20 0.52
NPC1 O15118 4/20 0.52
KMT2A Q03164 4/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
MEN1 O00255 3/20 0.52
LMNA P02545 3/20 0.52
TDP1 Q9NUW8 2/20 0.52
MAPK1 P28482 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
POLB P06746 1/20 0.52
MMP14 P50281 1/20 0.52
ALDH1A1 P00352 7/20 0.44
PSMD14 O00487 1/20 0.43
MITF O75030 1/20 0.43
S100B P04271 1/20 0.42
GAA P10253 3/20 0.40
HTT P42858 3/20 0.40
PKM P14618 1/20 0.40
MCL1 Q07820 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL8745489 0.94 MAPT (0.48) MAPTRAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL11626822 0.92 MAPT (0.59) MAPTRAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL9365786 0.91 S100B (0.47) MAPTRAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL6315517 0.87 S100B (0.55) MAPTRAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL9888766 0.85 MAPT (0.52) MAPTRAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL13412506 0.80 S1PR1 (0.56) MAPTRAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL14573726 0.80 MAPT (0.41) MAPTRAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL6310009 0.78 S100B (0.40) MAPTRAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL10412003 0.78 MAPT (0.54) MAPTRAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL10486091 0.78 S100B (0.47) MAPTRAB9ANPC1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050037294-A1 Stabilized p-phenylenediamine-type photographic color developers in free base form HUDNALL PHILLIP MONTGOMERY (US) 2005-02-17 US claimed
EP-1327181-A2 STABILIZED p-PHENYLENEDIAMINE-TYPE PHOTOGRAPHIC COLOR DEVELOPERS IN FREE BASE FORM EASTMAN CHEMICAL COMPANY (US) 2003-07-16 EP claimed
US-20020072017-A1 Stabilized p-phenylenediamine-type photographic color developers in free base form EASTMAN CHEMICAL COMPANY 2002-06-13 US claimed
WO-2002033486-A2 STABILIZED p-PHENYLENEDIAMINE-TYPE PHOTOGRAPHIC COLOR DEVELOPERS IN FREE BASE FORM EASTMAN CHEMICAL COMPANY (US) 2002-04-25 WO claimed
US-5475140-A Process for producing N,N-disubstituted p-phenylenediamine derivative sulfate WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 1995-12-12 US claimed
US-20070073059-A1 Method of producing azomethine dye compound FUJI PHOTO FILM CO., LTD. 2007-03-29 US disclosed
US-20070073059-A1 Method of producing azomethine dye compound FUJI PHOTO FILM CO., LTD. 2007-03-29 US disclosed
US-20050037294-A1 Stabilized p-phenylenediamine-type photographic color developers in free base form HUDNALL PHILLIP MONTGOMERY (US) 2005-02-17 US disclosed
EP-1327181-A2 STABILIZED p-PHENYLENEDIAMINE-TYPE PHOTOGRAPHIC COLOR DEVELOPERS IN FREE BASE FORM EASTMAN CHEMICAL COMPANY (US) 2003-07-16 EP disclosed
US-20020072017-A1 Stabilized p-phenylenediamine-type photographic color developers in free base form EASTMAN CHEMICAL COMPANY 2002-06-13 US disclosed
WO-2002033486-A2 STABILIZED p-PHENYLENEDIAMINE-TYPE PHOTOGRAPHIC COLOR DEVELOPERS IN FREE BASE FORM EASTMAN CHEMICAL COMPANY (US) 2002-04-25 WO disclosed
US-4474987-A Process for preparing N,N-disubstituted p-phenylenediamine derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070073059-A1 Method of producing azomethine dye compound RNF31, RPL31, O60361 MAPT 3479/4885RAB9A 2286/4885NPC1 3679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.